[CAS NO. 686347-12-6]  Otenabant (CP-945598) HCl

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [686347-12-6]

Store
Catalog
SLK-S8012
Brand
Selleck
CAS
686347-12-6

DESCRIPTION [686347-12-6]

Overview

MDL-
Molecular Weight546.88
Molecular FormulaC25H25Cl2N7O.HCl
SMILESClC1=C(C=2N(C=3C(N2)=C(N=CN3)N4CCC(NCC)(C(N)=O)CC4)C5=CC=C(Cl)C=C5)C=CC=C1.Cl

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM1.8286 mL9.1428 mL18.2855 mL
5 mM0.3657 mL1.8286 mL3.6571 mL
10 mM---
50 mM---

Description

Otenabant (CP-945598) HCl is a potent and selective antagonist with of 0.7 nM, exhibits 10,000-fold greater selectivity against human CB2 receptor. Phase 1.

Targets

hCB1 [1]rCB1 [2]
0.7 nM(Ki)2.8 nM(Ki)

In vitro

CP-945598 HCl inhibits CB receptor with moderate unbound microsomal clearance, low hERG affinity, and adequate CNS penetration. CP-945598 HCl has low affinity with K of 7.6 μM for human CB receptors.

In vivo

CP-945598 HCl reverses four cannabinoid agonistmediated behaviors (locomotor activity, hypothermia, analgesia, and catalepsy) following administration of the synthetic CB receptor agonist CP-55940. CP-945598 HCl exhibits dose-dependent anorectic activity in a model of acute food intake in rodents and increased energy expenditure and fat oxidation. CP-945598 also acutely stimulates energy expenditure in rats and decreases the respiratory quotient indicating a metabolic switch to increased fat oxidation. CP-945598 at 10 mg/kg promotes a 9%, vehicle adjusted weight loss in a 10 day weight loss study in diet-induced obese mice.


Synonyms

4-Piperidinecarboxamide, 1-[8-(2-chlorophenyl)-9-(4-chlorophenyl)-9H-purin-6-yl]-4-(ethylamino)-, hydrochloride (1:1)
4-Piperidinecarboxamide, 1-[8-(2-chlorophenyl)-9-(4-chlorophenyl)-9H-purin-6-yl]-4-(ethylamino)-, monohydrochloride
Otenabant hydrochloride
CP 945598
CP 945598-01